X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (495) 495
1-deoxynojirimycin - analogs & derivatives (429) 429
humans (378) 378
1-deoxynojirimycin - therapeutic use (236) 236
male (214) 214
animals (197) 197
female (168) 168
1-deoxynojirimycin - pharmacology (147) 147
enzyme inhibitors - therapeutic use (141) 141
mice (117) 117
glycoside hydrolase inhibitors (112) 112
adult (110) 110
middle aged (104) 104
1-deoxynojirimycin (99) 99
glucosamine - analogs & derivatives (99) 99
miglustat (84) 84
diabetes mellitus, type 2 - drug therapy (82) 82
hypoglycemic agents - therapeutic use (79) 79
1-deoxynojirimycin - administration & dosage (77) 77
biochemistry & molecular biology (75) 75
pharmacology & pharmacy (74) 74
glucosamine - therapeutic use (73) 73
n-butyldeoxynojirimycin (73) 73
imino pyranoses (71) 71
treatment outcome (71) 71
endocrinology & metabolism (68) 68
aged (65) 65
gaucher disease - drug therapy (65) 65
genetics & heredity (62) 62
enzyme inhibitors - pharmacology (59) 59
medicine, research & experimental (56) 56
niemann-pick disease, type c - drug therapy (56) 56
enzymes (53) 53
adolescent (52) 52
blood glucose - metabolism (51) 51
disease models, animal (51) 51
enzyme replacement therapy (50) 50
1-deoxynojirimycin - adverse effects (48) 48
child (48) 48
pharmacology (45) 45
rats (44) 44
care and treatment (43) 43
diabetes mellitus, type 2 - blood (42) 42
disease (42) 42
medicine (42) 42
research (42) 42
1-deoxynojirimycin - chemistry (41) 41
biosynthesis (41) 41
time factors (41) 41
chemistry, organic (39) 39
analysis (38) 38
glucose (38) 38
substrate reduction therapy (38) 38
acarbose (37) 37
gaucher disease (37) 37
glucosamine - pharmacology (37) 37
miglitol (37) 37
mutation (37) 37
diabetes (36) 36
insulin - blood (36) 36
health aspects (35) 35
hypoglycemic agents - pharmacology (35) 35
internal medicine (35) 35
pediatrics (35) 35
medicine & public health (34) 34
double-blind method (33) 33
enzyme inhibitors - administration & dosage (33) 33
child, preschool (32) 32
glucosyltransferases - antagonists & inhibitors (32) 32
alpha-glucosidase inhibitor (31) 31
chemistry, medicinal (30) 30
dose-response relationship, drug (30) 30
enzyme inhibitors - adverse effects (30) 30
physiological aspects (30) 30
young adult (30) 30
abridged index medicus (29) 29
derivatives (28) 28
glucosylceramidase - therapeutic use (28) 28
niemann-pick disease (28) 28
therapy (28) 28
cholesterol (27) 27
drug therapy, combination (27) 27
fabry disease - drug therapy (27) 27
inhibitor (27) 27
lysosomal storage (27) 27
medicine, general & internal (27) 27
genetics (26) 26
inhibitors (26) 26
type 2 diabetes (26) 26
diabetes mellitus (25) 25
gangliosides (25) 25
infant (25) 25
gaucher-disease (24) 24
glycosphingolipids - metabolism (24) 24
inhibition (24) 24
neurosciences (24) 24
alpha-galactosidase - genetics (23) 23
article (23) 23
children (23) 23
efficacy (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (527) 527
French (15) 15
German (11) 11
Japanese (5) 5
Spanish (3) 3
Hungarian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2014, Volume 16, Issue 8, pp. 761 - 765
We assessed the efficacy and safety of sitagliptin compared with α‐glucosidase inhibitor ( αGI ) in 120 of Japanese patients with type 2 diabetes mellitus (... 
type 2 diabetes | DPP‐IV | inhibitor | sulphonylureas | α‐glucosidase inhibitor | randomized trial | Type 2 diabetes | Randomized trial | α-glucosidase inhibitor | Sulphonylureas | DPP-IV inhibitor | VOGLIBOSE | MONOTHERAPY | HYPERGLYCEMIA | DOUBLE-BLIND TRIAL | alpha-glucosidase inhibitor | ENDOCRINOLOGY & METABOLISM | MELLITUS | Glycated Hemoglobin A - analysis | Triazoles - adverse effects | Glycoside Hydrolase Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Hypoglycemia - prevention & control | 1-Deoxynojirimycin - therapeutic use | Drug Therapy, Combination - adverse effects | Inositol - therapeutic use | Inositol - adverse effects | 1-Deoxynojirimycin - analogs & derivatives | Female | 1-Deoxynojirimycin - adverse effects | Sitagliptin Phosphate | Hypoglycemia - chemically induced | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Japan | Sulfonylurea Compounds - therapeutic use | Inositol - analogs & derivatives | Diabetes Mellitus, Type 2 - blood | Gastrointestinal Agents - therapeutic use | Pyrazines - adverse effects | Aged | Gastrointestinal Agents - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | alpha-Glucosidases - metabolism | alpha-Glucosidases - chemistry | Index Medicus
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 2010, Volume 44, Issue 1, pp. 41 - 47
Journal Article
Journal Article
Journal Article
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 6, pp. 545 - 555
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, pp. e0134341 - e0134341
Journal Article
Journal Article